Purchase Order HT941025PE037
Award Date 10/1/25
Potential Completion Date 9/30/30
Potential Value $69K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sheridan, CO 80110, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $165,059.64 firm-fixed-price delivery order for reagents to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The award was not set aside under a socioeconomic program. Life Technologies serves as a prime contractor across various federal agencies, including the NIH, DoD, USDA, DOC, and DOJ, providing laboratory equipment, reagents, and associated services to support healthcare, medical readiness,...
- The Defense Logistics Agency awarded a $24,529.17 delivery order to AmerisourceBergen Drug Corp for 75-unit vials of Menopur, a fertility medication used in assisted reproductive procedures. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 24, 2025, with performance to be completed in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. This delivery order...
- The Defense Health Agency awarded a firm fixed-price purchase order to Quidelortho Sales Company, LLC on June 2, 2023, for the procurement of immunohematology blood reagents and blood testing reagents with a ceiling value of $429,747.74. The contract is scheduled for ultimate completion on May 31, 2026, and will be performed at Eglin Air Force Base in Florida. This award does not include a set-aside designation for small businesses or other protected categories. Quidelortho Sales Company, LLC, a...
- The Defense Health Agency awarded a mission-critical contract to Phadia US Inc.'s Immunodiagnostics Division on August 1, 2025, valued at $49,920.38 through a Blanket Purchase Agreement (BPA) call. This firm-fixed-price order procures specialized allergy testing reagents required to support healthcare providers across San Antonio military treatment facilities and other Department of Defense medical installations. The reagents are essential for the detection and management of allergic...
- <p>The Defense Health Agency (DOD) awarded a $803,659.42 firm fixed price delivery order contract to Life Technologies Corporation for reagents and consumables. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division, will provide the reagents and consumables from its place of performance in Carlsbad, California, starting May 6, 2022 through completion on September 6, 2022.</p>
- The Defense Health Agency awarded a $301,450.35 firm fixed-price purchase order to Henry Schein, Inc.'s USDG Federal Division for the supply of laboratory reagents. The contract, issued on October 1, 2023, will be performed in Huntington Station, New York, with a completion date of September 30, 2028. This procurement reflects the Defense Health Agency's ongoing need for laboratory consumables to support military healthcare operations and diagnostic capabilities across its medical facilities and...
- The Defense Health Agency awarded a $228,353.45 firm fixed-price purchase order to Werfen USA LLC for blood typing reagents, with an ultimate completion date of September 30, 2027. This contract, which became effective on October 1, 2022, involves a novation agreement reflecting a change of name for the contractor. The place of performance is El Paso, Texas, where the reagents will be supplied to support clinical laboratory operations. The contract carries no small business set-aside...
- The Defense Health Agency awarded a $172,221.60 firm fixed-price delivery order to Ortho-Clinical Diagnostics, Inc. for blood bank microtyping system reagents, with an ultimate completion date of September 30, 2030. This delivery order, issued without a set-aside designation, represents an open competition award under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule. Performance will occur at Ortho-Clinical Diagnostics' facility in Raritan, New Jersey, where the company...
- The Defense Logistics Agency (DLA) awarded a $30,760.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.44ML, a pharmaceutical product used in fertility treatment. This non-set-aside award, issued on July 18, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Health Agency awarded a $30,041.39 firm fixed-price call under an existing Blanket Purchase Agreement (BPA) to Ortho Clinical Diagnostics K.K. on July 25, 2025, for chemistry and immunoassay testing system reagents and supplies. The contract, which carries no socioeconomic set-aside designation, is scheduled for completion by September 30, 2025, and will be performed in Japan. Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global in vitro diagnostic solutions...